Association of long non-coding RNAs (lncRNAs) ANRIL and MALAT1 polymorphism with cervical cancer

Loading...
Thumbnail Image
Authors
Yao, Yueting
Liang, Yan
Dong, Xudong
Liu, Shuyuan
Zhang, Shao
Liu, Weipeng
Li, Yu
Shi, Li
Yan, Zhiling
Yao, Yufeng
Issue Date
2022-04-21
Type
Article
Language
en_US
Keywords
Cervical Cancer , Single-Nucleotide Polymorphisms , Long Non-Coding RNAs , Association Study
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Background: Long non-coding RNAs (lncRNAs) and their polymorphisms play crucial roles in the development of different cancers. Methods: Eight single-nucleotide polymorphisms (SNPs) in ANRIL and MALAT1 (rs1333045, rs4977574, rs1333048, and rs10757278 in ANRIL and rs11227209, rs619586, rs664589, and rs3200401 in MALAT1) were enrolled and genotyped in a total of 1248 samples, including 587 patients with cervical cancer (CC) and 661 healthy individuals using in TaqMan assay. The association of these SNPs with CC was then evaluated. Results: Our results showed that the allele and genotype frequencies of rs3200401 in MALAT1 were significantly different between the control and CC groups after Bonferroni correction (P = 0.001 and P = 0.004, respectively), indicating that the C allele is a protective factor against CC (OR = 0.70; 95% CI = 0.57–0.87). In addition, the allele and genotype frequencies of rs4977574 in ANRIL were significantly different between the control and CC groups after Bonferroni correction (P = 0.004 and P = 0.014, respectively), and the A allele might be a protective factor for CC (OR = 0.80; 95% CI = 0.68–0.93). For subgroup analysis, the alleles of rs3200401 in MALAT1 showed significant differences between the control and adenocarcinoma (AC) and control and squamous cell carcinoma (SCC) groups (P = 0.005 and P = 0.004, respectively). The rs3200401C allele could be a protective factor for AC and SCC development (OR = 0.57; 95% CI = 0.38–0.85; OR = 0.72; 95% CI = 0.58–0.90). Moreover, the rs3200401C allele could be a protective factor for cervical cancer stage I development (OR = 0.67; 95% CI = 0.53–0.86). Conclusion: Our results indicate that rs3200401 in MALAT1 and rs4977574 in ANRIL could play key roles in the CC development.
Description
Citation
Yao, Y., Liang, Y., Dong, X., Liu, S., Zhang, S., Liu, W., Li, Y., Shi, L., Yan, Z., & Yao, Y. (2022). Association of Long Non-Coding RNAs (lncRNAs) ANRIL and MALAT1 Polymorphism with Cervical Cancer. Pharmacogenomics and personalized medicine, 15, 359–375. https://doi.org/10.2147/PGPM.S358453
Publisher
Pharmacogenomics and Personalized Medicine
Journal
Volume
Issue
PubMed ID
DOI
ISSN
EISSN